HIV-1 infection of human macrophages directly induces viperin which inhibits viral production

Blood

Volumn 120, Issue 4, 2012, Pages 778-788

  Nasr, Najla ^a   Maddocks, Susan ^a   Turville, Stuart G ^a   Harman, Andrew N ^a   Woolger, Natalie ^a   Helbig, Karla J ^b   Wilkinson, John ^a   Bye, Chris R ^c   Wright, Thomas K ^a   Rambukwelle, Dharshini ^a   Donaghy, Heather ^a   Beard, Michael R ^b   Cunningham, Anthony L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOL; INTERFERON REGULATORY FACTOR 3; INTERFERON STIMULATED GENE FACTOR 3; MEMBRANE PROTEIN; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG; VIPERIN;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIPID RAFT; MACROPHAGE; MONOCYTE; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PRENYLATION;

EID: 84864491073     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-407395     Document Type: Article

References (48)

1. Meltzer MS, Gendelman HE. Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease. Curr Top Microbiol Immunol. 1992;181:239-263.
2. Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem. 2002;9(21):1893-1903. (Pubitemid 35230257)
3. Chen HY, Di Mascio M, Perelson AS, Ho DD, Zhang L. Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques. Proc Natl Acad Sci U S A. 2007;104(48):19079-19084.
4. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol. 1993;67(4):2182-2190. (Pubitemid 23088394)
5. Naif HM, Li S, Alali M, et al. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins. J Virol. 1999;73(6):4866-4881. (Pubitemid 29246747)
6. Sonza S, Mutimer HP, O'Brien K, et al. Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. J Virol. 2002;76(24):12611-12621. (Pubitemid 35386946)
7. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474(7353):658-661.
8. Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675-687. (Pubitemid 37328725)
9. de Veer MJ, Holko M, Frevel M, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001;69(6):912-920.
10. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol. 2008;8(7):559-568. (Pubitemid 351913674)
11. O'Neill LA, Bowie AG. Sensing and signaling in antiviral innate immunity. Curr Biol. 2010;20(7):R328-R333.
12. Yoneyama M, Fujita T. Recognition of viral nucleic acids in innate immunity. Rev Med Virol. 2010;20(1):4-22.
13. Gendelman HE, Friedman RM, Joe S, et al. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med. 1990;172(5):1433-1442. (Pubitemid 20366219)
14. Gessani S, Puddu P, Varano B, et al. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J Virol. 1994;68(3):1983-1986. (Pubitemid 24065771)
15. Kornbluth RS, Oh PS, Munis JR, Cleveland PH, Richman DD. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J Exp Med. 1989;169(3):1137-1151. (Pubitemid 19085845)
16. Perno CF, Aquaro S, Rosenwirth B, et al. In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages. J Leukoc Biol. 1994;56(3):381-386. (Pubitemid 24295810)
17. Woelk CH, Ottones F, Plotkin CR, et al. Interferon gene expression following HIV type 1 infection of monocyte-derived macrophages. AIDS Res Hum Retroviruses. 2004;20(11):1210-1222. (Pubitemid 39557871)
18. Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J Virol. 2009;83(20):10395-10405.
19. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology. 2008;373(1):85-97.
20. Harman AN, Lai J, Turville S, et al. HIV infection of dendritic cells subverts the interferon induction pathway via IRF1 and inhibits type 1 interferon production. Blood. 2011;118(2):298-308.
21. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A. 2001;98(26):15125-15130. (Pubitemid 34013980)
22. Helbig KJ, Lau DT, Semendric L, Harley HA, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. 2005;42(3):702-710. (Pubitemid 41233665)
23. Helbig KJ, Eyre NS, Yip E, et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology. 2011;54(5):1506-1517.
24. Harman AN, Wilkinson J, Bye CR, et al. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol. 2006;177(10):7103-7113. (Pubitemid 44715078)
25. Turville SG, Santos JJ, Frank I, et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood. 2004;103(6):2170-2179. (Pubitemid 38326235)
26. Harman AN, Kraus M, Bye CR, et al. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood. 2009;114(1):85-94.
27. Lewin SR, Vesanen M, Kostrikis L, et al. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy. J Virol. 1999;73(7):6099-6103. (Pubitemid 29274900)
28. Turville SG, Aravantinou M, Stossel H, Romani N, Robbiani M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat Methods. 2008;5(1):75-85.
29. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. In: Statistical Applications in Genetics and Molecular Biology. Berkeley, CA: Bepress; 2004;3:Article3.
30. Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):P3.
31. Estaquier J, Lelievre JD, Petit F, et al. Effects of antiretroviral drugs on human immunodeficiency virus type 1-induced CD4(+) T-cell death. J Virol. 2002;76(12):5966-5973. (Pubitemid 34556291)
32. Fensterl V, Sen GC. The ISG56/IFIT1 gene family. J Interferon Cytokine Res. 2011;31(1):71-78.
33. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol. 2011;85(5):2126-2137.
34. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol. 2007;177(2):329-341. (Pubitemid 46658643)
35. Carter GC, Bernstone L, Sangani D, Bee JW, Harder T, James W. HIV entry in macrophages is dependent on intact lipid rafts. Virology. 2009;386(1):192-202.
36. Wang X, Hinson ER, Cresswell P. The interferoninducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe. 2007;2(2):96-105. (Pubitemid 47209520)
37. Szkopińska A, Plochocka D. Farnesyl diphosphate synthase: regulation of product specificity. Acta Biochim Pol. 2005;52(1):45-55. (Pubitemid 41132175)
38. Ye J, Wang C, Sumpter R Jr, Brown MS, Goldstein JL, Gale M Jr. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A. 2003;100(26):15865-15870. (Pubitemid 38021081)
39. Coberley CR, Kohler JJ, Brown JN, et al. Impact on genetic networks in human macrophages by a CCR5 strain of human immunodeficiency virus type 1. J Virol. 2004;78(21):11477-11486. (Pubitemid 39390735)
40. Boudinot P, Riffault S, Salhi S, et al. Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways. J Gen Virol. 2000;81(11):2675-2682.
41. Ruvolo V, Navarro L, Sample CE, David M, Sung S, Swaminathan S. The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression. J Virol. 2003;77(6):3690-3701. (Pubitemid 36297288)
42. Hinson ER, Cresswell P. The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J Biol Chem. 2009;284(7):4705-4712.
43. Grigorov B, Arcanger F, Roingeard P, Darlix JL, Muriaux D. Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J Mol Biol. 2006;359(4):848-862. (Pubitemid 43842051)
44. Jiang D, Guo H, Xu C, et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol. 2008;82(4):1665-1678. (Pubitemid 351206918)
45. Wang S, Wu X, Pan T, et al. Viperin inhibits hepatitis C virus replication by interfering with the binding of NS5A to host protein hVAP-33. J Gen Virol. 2012;93(1):83-92.
46. Leung K, Kim JO, Ganesh L, Kabat J, Schwartz O, Nabel GJ. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions. Cell Host Microbe. 2008;3(5):285-292. (Pubitemid 351636000)
47. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A. 2006;103(5):1440-1445. (Pubitemid 43191184)
48. Rivieccio MA, Suh HS, Zhao Y, et al. TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol. 2006;177(7):4735-4741. (Pubitemid 44469807)